title: Multiparametric magnetic resonance imaging of prostate cancer.
abstract: In India, prostate cancer has an incidence rate of 3.9 per 100,000 men and is responsible for 9% of cancer-related mortality. It is the only malignancy that is diagnosed with an apparently blind technique, i.e., transrectal sextant biopsy. With increasing numbers of high-Tesla magnetic resonance imaging (MRI) equipment being installed in India, the radiologist needs to be cognizant about endorectal MRI and multiparametric imaging for prostate cancer. In this review article, we aim to highlight the utility of multiparamteric MRI in prostate cancer. It plays a crucial role, mainly in initial staging, restaging, and post-treatment follow-up.
authors.affiliation: Department of Abdominal Imaging and Intervention, Massachusetts General Hospital 55 Fruit St, Boston, 02114 Massachusetts, USA.
authors.forename: Sandeep S
authors.initials: SS
authors.lastname: Hedgire
authors.forename: Tamara N
authors.initials: TN
authors.lastname: Oei
authors.forename: Shaunagh
authors.initials: S
authors.lastname: McDermott
authors.forename: Kai
authors.initials: K
authors.lastname: Cao
authors.forename: Zena
authors.initials: Z
authors.lastname: Patel M
authors.forename: Mukesh G
authors.initials: MG
authors.lastname: Harisinghani
keywords: Diffusion-weighted imaging; dynamic contrast-enhanced-magnetic resonance imaging; magnetic resonance imaging; prostate cancer